Insider Transactions in Q2 2025 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
20,000
-1.14%
|
-
|
|
Jun 13
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
BUY
Bona fide gift
|
Indirect |
9,600
+41.56%
|
-
|
|
Jun 13
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
9,600
-0.54%
|
-
|
|
Jun 02
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
24,000
-6.65%
|
$264,000
$11.0 P/Share
|
|
May 20
2025
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,364
-0.86%
|
$138,276
$9.45 P/Share
|
|
May 20
2025
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
9,743
-2.47%
|
$87,687
$9.45 P/Share
|
|
May 20
2025
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,348
-2.5%
|
$84,132
$9.45 P/Share
|
|
May 20
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
9,120
-2.46%
|
$82,080
$9.45 P/Share
|
|
May 20
2025
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
SELL
Payment of exercise price or tax liability
|
Direct |
9,701
-4.32%
|
$87,309
$9.45 P/Share
|
|
May 19
2025
|
Deepika Pakianathan |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+15.5%
|
-
|
|
May 19
2025
|
Aine Miller SVP, DEV & HEAD OF IRE OFFICE |
BUY
Grant, award, or other acquisition
|
Direct |
10,430
+4.44%
|
-
|
|
May 19
2025
|
Dean J Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+10.46%
|
-
|
|
May 19
2025
|
Donal O'Connor |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+12.55%
|
-
|
|
May 19
2025
|
Jeremy T Grant |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+24.42%
|
-
|
|
May 19
2025
|
Susannah Gray |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+20.17%
|
-
|
|
May 19
2025
|
Alsup Laurie Smaldone |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+12.44%
|
-
|
|
May 19
2025
|
Eran Broshy |
BUY
Grant, award, or other acquisition
|
Direct |
10,649
+10.46%
|
-
|
|
Apr 21
2025
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
4,000
-1.07%
|
$36,000
$9.0 P/Share
|